Clinical Trials
303
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (198 trials with phase data)• Click on a phase to view related trials
Impact of Antepartum Breast Milk Expression on Breastfeeding Rates in Patients With Gestational Diabetes Mellitus
- Conditions
- Gestatiaonl Diabetes Mellitus
- First Posted Date
- 2025-08-19
- Last Posted Date
- 2025-08-19
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 212
- Registration Number
- NCT07128433
Telitacicept for PGNMID: A Single-Arm Study
- Conditions
- Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
- Interventions
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT07111338
- Locations
- 🇨🇳
Peking University First Hospital, Renal Division, Beijing, Beijing, China
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
- Conditions
- Renal Artery Stenosis AtheroscleroticSecondary Hypertension Renal Arterial
- Interventions
- Diagnostic Test: renal artery fractional flow reserve measurementDevice: renal artery stentOther: sham stenting
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT07111442
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Multi-omics Studies of Primary Aldosteronism
- Conditions
- Primary Aldosteronism
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT07111351
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
- Conditions
- Deep LearningUltrasoundBladder Cancer
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT07111364
- Locations
- 🇨🇳
Department of Urology, Peking University First Hospital, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 59
- Next
News
Cellular Senescence Gene Signature Reveals New Biomarkers for Idiopathic Pulmonary Fibrosis
Researchers identified four key cellular senescence-related genes (CDKN2A, VEGFA, SOX2, and FOXO3) that could serve as diagnostic biomarkers for idiopathic pulmonary fibrosis (IPF).
Everest Medicines Reports Promising Phase 1b/2a Results for EVER001 BTK Inhibitor in Primary Membranous Nephropathy
Everest Medicines presented positive Phase 1b/2a trial results for EVER001, a next-generation covalent reversible BTK inhibitor, showing significant efficacy in treating primary membranous nephropathy at the 62nd European Renal Association Congress.
Meta-Analysis Confirms Efficacy of Traditional Chinese Medicine Si-Shen-Wan for Treating IBS-D
A comprehensive meta-analysis of 34 randomized controlled trials involving 2,976 participants has validated the efficacy of Si-Shen-Wan (SSW) in treating diarrhea-predominant irritable bowel syndrome.
VivaVision's VVN461 Shows Promising Results in Phase 2 Trial for Non-Infectious Anterior Uveitis
VivaVision Biotech's dual JAK1/TYK2 inhibitor VVN461 demonstrated non-inferior efficacy to prednisolone acetate in treating non-infectious anterior uveitis in a Phase 2 trial conducted across 10 clinical sites in China.